Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Pre-Treatment	STARTED	Nivolumab 3mg/kg	240
Pre-Treatment	STARTED	Investigators Choice	121
Pre-Treatment	COMPLETED	Nivolumab 3mg/kg	236
Pre-Treatment	COMPLETED	Investigators Choice	111
Pre-Treatment	NOT COMPLETED	Nivolumab 3mg/kg	4
Pre-Treatment	NOT COMPLETED	Investigators Choice	10
Treatment	STARTED	Nivolumab 3mg/kg	236
Treatment	STARTED	Investigators Choice	111
Treatment	COMPLETED	Nivolumab 3mg/kg	1
Treatment	COMPLETED	Investigators Choice	0
Treatment	NOT COMPLETED	Nivolumab 3mg/kg	235
Treatment	NOT COMPLETED	Investigators Choice	111

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02105636/flow